Plaque Psoriasis - Epidemiology Forecast to 2030

2021-09-30
Price :
Published : Sep-2021
No. of Pages : 34
Table of Contents
1 Plaque Psoriasis: Executive Summary
1.1 Catalyst
1.2 Related Reports
1.3 Upcoming Reports
2 Epidemiology
2.1 Disease Background
2.1.1 Risk Factors and Comorbidities
2.2 Global and Historical Trends
2.3 Forecast Methodology
2.3.1 Sources
2.3.2 Forecast Assumptions and Methods
2.4 Epidemiological Forecast for Plaque Psoriasis (2020-2030)
2.4.1 Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis
2.4.2 Age-Specific Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis
2.4.3 Sex-Specific Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis
2.4.4 Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis by Severity in the Adult Population
2.4.5 Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis with PsA in the Adult Population
2.5 Discussion
2.5.1 Epidemiological Forecast Insight
2.5.2 COVID-19 Impact
2.5.3 Limitations of the Analysis
2.5.4 Strengths of the Analysis
3 Appendix
3.1 Bibliography
3.2 About the Authors
3.2.1 Epidemiologist
3.2.2 Reviewers
3.2.3 Global Director of Therapy Analysis and Epidemiology
3.2.4 Global Head and EVP of Healthcare Operations and Strategy
3.3 Contact Us

List of Tables
Table 1: Summary of Newly Added Data Types and Countries
Table 2: Summary of Updated Data Types
Table 3: Risk Factors and Comorbidities for Plaque Psoriasis

List of Figures
Figure 1: 7MM, Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis, Both Sexes, All Ages, 2020 and 2030 (N)
Figure 2: 7MM, Lifetime Diagnosed Prevalence of Pediatric Plaque Psoriasis (%), Boys and Girls, Ages ?17 Years, 2020
Figure 3: 7MM, Lifetime Diagnosed Prevalence of Adult Plaque Psoriasis (%), Men and Women, Ages ?18 Years, 2020
Figure 4: Sources Used for Lifetime Diagnosed Prevalent Cases of Pediatric Plaque Psoriasis
Figure 5: Sources Used and Not Used for Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis in Adults
Figure 6: Sources Used for Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis by Severity Among Adults
Figure 7: Sources Used for Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis with PsA Among Adults
Figure 8: 7MM, Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis, Men and Women, All Ages, 2020 (N)
Figure 9: Age-Specific Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis, 7MM, Men and Women, 2020 (N)
Figure 10: 7MM, Sex-Specific Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis, All Ages, 2020 (N)
Figure 11: 7MM, Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis by Severity, Men and Women, ?18 Years, 2020
Figure 12: 7MM, Lifetime Diagnosed Prevalent Cases of Plaque Psoriasis with Psoriatic Arthritis, Men and Women, ?18 Years, 2020 (N)
Filed in: Pharmaceutical
Publisher : GlobalData